0001231919-26-001488.txt : 20261022 0001231919-26-001488.hdr.sgml : 20261022 20261022124416 ACCESSION NUMBER: 0001231919-26-001488 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261022 DATE AS OF CHANGE: 20261022 EFFECTIVENESS DATE: 20261022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Altrartis Therapeutics Inc. CENTRAL INDEX KEY: 0002157050 ORGANIZATION NAME: EIN: 384376720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-602187 FILM NUMBER: 261478193 BUSINESS ADDRESS: STREET 1: 228 PARK AVE S # 505778 CITY: NEW YORK STATE: NY ZIP: 10003-1502 BUSINESS PHONE: 49 211 87973990185 MAIL ADDRESS: STREET 1: 228 PARK AVE S # 505778 CITY: NEW YORK STATE: NY ZIP: 10003-1502 D 1 primary_doc.xml X0708 D LIVE 0002157050 Altrartis Therapeutics Inc. 228 PARK AVE S # 505778 NEW YORK NY NEW YORK 10003-1502 49 211 87973990185 DELAWARE None None Corporation true 2025 Florian Brand c/o Altrartis Therapeutics Inc. 228 Park Ave S # 505778 New York NY NEW YORK 10003-1502 Executive Officer Director Promoter Lars Christian Wilde c/o Altrartis Therapeutics Inc. 228 Park Ave S # 505778 New York NY NEW YORK 10003-1502 Director Other Decline to Disclose 06b false 2026-08-12 false true false 0 10999977 10999977 0 false 11 0 0 0 false Altrartis Therapeutics Inc. /s/ Florian Brand Florian Brand Chief Executive Officer 2026-10-22